Non-Invasive Blood Pressure Monitor Accuracy in Neonatal Subjects

NCT ID: NCT02642198

Last Updated: 2016-03-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being conducted to validate the accuracy of non-invasive blood pressure (NIBP) measurement technology from Mortara Instrument, Inc. (Milwaukee, Wisconsin, USA) and Zoe Medical, Inc. (Topsfield, Massachusetts, USA) in a neonatal, infants and children up to 3 years old patient population. The study is defined according to the International Standard "ANSI/AAMI/ISO 81060-2:2013, Non-invasive sphygmomanometers - Part 2: Clinical investigation of automated measurement type".

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The device under test is Mortara Instrument's Surveyor S12/S19 patient monitors ("Surveyor") incorporating neonatal NIBP technology. Specifically, NIBP measurements will be taken using a cuff on the patient's limb (exact location will be determined by clinician) using a variety of cuffs sized for neonates and pediatrics. The device utilizes oscillometric technology to obtain quickly and conveniently non-invasive blood pressure measurements. Results will be compared to invasive blood pressure measurements from patients already monitored with such sensors. The Device under Test will be calibrated and verified by a Mortara representative on site.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-invasive Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surveyor S12 and S19 patient monitor

Non-invasive blood pressure measurement

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

S12/S19

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Before proceeding with the blood pressure non-invasive measurements detection, patients shall be examined and met the following stated criteria:

* Patients shall have already an invasive blood pressure monitoring (with catheter), this criteria applies only for Method 1.
* It shall be possible to perform multiple measurements of Non Invasive Blood pressure on one or more limbs with inflatable cuff.
* Patient with weight and age range according to the protocol requirements previously defined.

Exclusion Criteria

* Patients with unstable clinical or cardiovascular conditions;
* Patients with circulatory problems which can results in different blood pressure values in the limbs;
* patients with heart disease which can results in blood pressure wave morphology abnormalities;
* patients where the difference of systolic blood pressure between two limbs is greater than 15 mm Hg or the difference of lateral diastolic blood pressure is greater than 10mmHg;
* Patients with arrhythmias.
Minimum Eligible Age

29 Days

Maximum Eligible Age

3 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mortara Instrument

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ospedale Pediatrico Bambino Gesù (OPBG)

Rome, Italy, Italy

Site Status RECRUITING

U.O. Neonatal Intensive Care Immature Pediatric Hospital Bambino Gesù - IRCCS

Rome, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fiammetta Piersigilli, MD

Role: CONTACT

06 - 6859 ext. 2427

Zaccaria Ricci

Role: CONTACT

06 - 6859 ext. 2258

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fiammetta Piersigilli, Doctor

Role: primary

06 - 6859 ext. 2427

Zaccaria Ricci, Doctor

Role: backup

06 - 6859 ext. 2258

Fiammetta Piersigilli, Doctor

Role: primary

06 - 6859 ext. 2427

Zaccaria Ricci, Doctor

Role: backup

06 - 6859 ext. 2258

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

900_OPBG_2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.